Getinge Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Getinge wird ein jährliches Gewinn- und Umsatzwachstum von 22% bzw. 5.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 21.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.4% betragen.

Wichtige Informationen

22.0%

Wachstumsrate der Gewinne

21.6%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	33.3%
Wachstumsrate der Einnahmen	5.8%
Zukünftige Eigenkapitalrendite	10.4%
Analystenabdeckung	Good
Zuletzt aktualisiert	15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 21

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Apr 25

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Mar 30

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Feb 04

Recent updates

An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued

Aug 08

Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 21

We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)

Jun 27

Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly

May 11

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Apr 25

Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?

Apr 15

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Mar 30

Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Mar 29

The Return Trends At Getinge (STO:GETI B) Look Promising

Mar 21

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Feb 04

There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price

Jan 20

Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly

Jan 05

Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price

Dec 20

Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)

Dec 05

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Oct 06

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?

Sep 21

Getinge's (STO:GETI B) Returns On Capital Are Heading Higher

Sep 03

Is Getinge (STO:GETI B) A Risky Investment?

Jun 28

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?

Jun 15

Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist

Jun 01

At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?

May 05

Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Apr 05

Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement

Feb 28

Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?

Feb 16

Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year

Feb 04

Is Getinge (STO:GETI B) Using Too Much Debt?

Feb 03

When Should You Buy Getinge AB (publ) (STO:GETI B)?

Jan 07

Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 49%?

Nov 06

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Oct 07

We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt

Jun 25

Gewinn- und Umsatzwachstumsprognosen

OM:GETI B - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SEK Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	38,026	3,386	3,711	5,151	9
12/31/2025	36,191	2,925	3,198	4,567	9
12/31/2024	34,171	2,059	2,817	4,441	9
9/30/2024	33,591	1,691	2,566	3,862	N/A
6/30/2024	33,328	2,584	3,279	4,593	N/A
3/31/2024	32,199	2,285	3,263	4,633	N/A
12/31/2023	31,827	2,412	1,604	2,957	N/A
9/30/2023	30,423	2,251	1,320	2,654	N/A
6/30/2023	29,756	2,154	1,252	2,519	N/A
3/31/2023	29,251	2,543	1,105	2,293	N/A
12/31/2022	28,292	2,491	2,231	3,367	N/A
9/30/2022	27,781	2,707	2,835	3,916	N/A
6/30/2022	27,146	2,665	3,085	4,135	N/A
3/31/2022	27,062	2,860	4,188	5,173	N/A
12/31/2021	27,049	2,970	5,630	6,560	N/A
9/30/2021	27,900	3,292	6,585	7,533	N/A
6/30/2021	29,571	3,916	6,893	7,811	N/A
3/31/2021	29,955	3,612	7,021	7,988	N/A
12/31/2020	29,819	3,239	6,154	7,199	N/A
9/30/2020	29,478	3,050	5,218	6,336	N/A
6/30/2020	27,738	1,878	4,239	5,437	N/A
3/31/2020	27,044	1,487	3,461	4,690	N/A
12/31/2019	26,559	1,222	2,612	3,832	N/A
9/30/2019	25,951	1,030	1,595	2,836	N/A
6/30/2019	25,398	-632	1,811	3,082	N/A
3/31/2019	24,852	-654	1,259	2,592	N/A
12/31/2018	24,172	-967	1,123	2,503	N/A
9/30/2018	23,653	-727	1,425	2,899	N/A
6/30/2018	22,914	847	N/A	2,371	N/A
3/31/2018	22,552	676	N/A	2,193	N/A
12/31/2017	22,495	1,096	N/A	2,763	N/A
9/30/2017	17,061	596	N/A	3,466	N/A
6/30/2017	19,046	390	N/A	3,599	N/A
3/31/2017	20,604	701	N/A	3,839	N/A
12/31/2016	22,170	698	N/A	3,671	N/A
9/30/2016	29,650	1,203	N/A	3,372	N/A
6/30/2016	29,646	1,462	N/A	3,369	N/A
3/31/2016	29,900	1,410	N/A	3,504	N/A
12/31/2015	30,235	1,390	N/A	3,458	N/A
9/30/2015	29,303	1,429	N/A	3,366	N/A
6/30/2015	28,603	1,622	N/A	3,386	N/A
3/31/2015	27,749	1,850	N/A	3,689	N/A
12/31/2014	26,669	1,433	N/A	3,473	N/A
9/30/2014	25,843	1,672	N/A	3,491	N/A
6/30/2014	25,468	1,718	N/A	3,674	N/A
3/31/2014	25,157	1,776	N/A	3,616	N/A
12/31/2013	25,287	2,285	N/A	3,544	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: GETI BDas prognostizierte Gewinnwachstum (22% pro Jahr) liegt über der Sparquote (1.2%).

Ertrag vs. Markt: GETI BDie Erträge des Unternehmens (22% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (15.2% pro Jahr).

Hohe Wachstumserträge: GETI BEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: GETI BDie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (0.06% pro Jahr).

Hohe Wachstumseinnahmen: GETI BDie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: GETI BDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.4%).

Getinge Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 11%

Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Getinge AB (Publ) Provides Sales Guidance for the Year 2024

Recent updates

Getinge Appoints Alexandra Holland Executive Vice President of Communications, Effective November 11, 2024

Independent Director recently bought kr473k worth of stock

Consensus EPS estimates fall by 11%

Non-Independent Director recently bought kr621k worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Getinge (STO:GETI B) Is Experiencing Growth In Returns On Capital

Independent Director recently bought kr1.1m worth of stock

Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly

Getinge AB (publ) (OM:GETI B) completed the acquisition of Paragonix Technologies, Inc. from Signet Healthcare Partners.

Independent Chairman recently bought kr4.3m worth of stock

Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire Paragonix Technologies, Inc. from Signet Healthcare Partners for approximately $480 million.

Pinning Down Getinge AB (publ)'s (STO:GETI B) P/E Is Difficult Right Now

An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued

Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Getinge AB (publ) to Report Q2, 2024 Results on Jul 18, 2024

We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)

Investor sentiment deteriorates as stock falls 18%

Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Getinge AB (publ) Declares A Dividend, Payable on 29 April 2024

Upcoming dividend of kr4.40 per share

Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Getinge AB (publ) to Report Fiscal Year 2024 Results on Jan 28, 2025

The Return Trends At Getinge (STO:GETI B) Look Promising

Dividend increased to kr4.40

Getinge AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Getinge AB (Publ) Proposes Dividend, Payable on April 29, 2024

Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Getinge AB (Publ) Provides Sales Guidance for the Year 2024

Getinge Announces CFO Changes

There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price

Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly

Price target increased by 8.4% to kr229

Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price

Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)

Price target increased by 7.0% to kr220

Consensus EPS estimates increase by 23%

Third quarter 2023 earnings: Revenues exceed analyst expectations

Getinge AB (publ) (OM:GETI B) acquired Healthmark Industries Company, Inc. for $320 million.

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Getinge's (STO:GETI B) Returns On Capital Are Heading Higher

Second quarter 2023 earnings: Revenues exceed analyst expectations

Getinge Receives US FDA 510(K) Clearance for Servo-Air® Lite

Is Getinge (STO:GETI B) A Risky Investment?

Consensus EPS estimates fall by 13%

Investor sentiment deteriorates as stock falls 22%

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?

Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire High Purity New England Inc. for approximately $290 million.

Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist

At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?

First quarter 2023 earnings: Revenues exceed analyst expectations

Now 22% undervalued

Upcoming dividend of kr4.25 per share at 1.6% yield

Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement

Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?

Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year

Getinge Provides Financial Guidance for the First Half, Second Half and Full Year of 2023

Is Getinge (STO:GETI B) Using Too Much Debt?

Full year 2022 earnings: EPS misses analyst expectations

Getinge AB (Publ) Proposes Dividend